OS biotechs walk away from Aussie deals
By Megan Brodie 1 year ago | In Companies, Industry, Reimbursement- 1 year ago
Specialised Therapeutics CEO Carlo Montagner
16 June 2025 The Trump Administration’s Most Favoured Nation (MFN) policy was specifically cited by…
This is subscriber-only content. Please login to continue reading.